TG Therapeutics' (TGTX) Q1 earnings miss sent shares down 13.4%, despite revenue growth & raised full-year guidance.
https://seekingalpha.com/news/4441064-tg-therapeutics-stock-sinks-on-profit-miss
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.